Should you bet on US stocks?
You don’t have to be bearish on US stocks to worry that they are now such a large share of global indices


American stocks have become a headache for many investors. Over the past 15 years, they have raced ahead of other major markets, to the point where they now account for more than 70% of the MSCI World index.
If you manage a fund benchmarked against that, you cannot afford to have too little in the US, because if it keeps beating everything else, your performance will lag badly and your job will be on the line.
This may be why some managers are saying that Donald Trump’s threats of raising tariffs on imports mean that the US will keep beating the world – they need a plausible reason to keep buying the US as it rises. In theory, tariffs should be bad news for growth and for stocks – being likely to hurt trade and push up inflation – but America is exceptional, they argue: it’s the world’s largest economy, the owner of the global reserve currency, the key source of import demand and so on. The rules that apply to other countries don’t apply to the superpower and its companies should suffer less than those in a trade war.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
This feels one-sided. Setting aside economic arguments around the impact of tariffs, note that US firms have been huge beneficiaries of globalisation, which could now make them equally huge targets for other governments. Domestically, there are obvious dangers in Trump’s arbitrary policies and whether he or some of his appointees will take aim at sectors such as tech or healthcare, or at any company that annoys him. Yes, the US could still beat the world – it remains the most innovative economy – but there are also reasons to fret about the tail risks that come with having 70% of assets in one country. So paring back the US can be about managing risk rather than being outright bearish.
How to hold US stocks
While most global funds, passive or active, are likely to have around 70% in the US, there are alternatives with lower exposure. The recently launched Invesco MSCI World Equal Weight ETF (LSE: MWEQ) invests the same amount in each stock, rather than weighting by market capitalisation. Since America has more giant companies and higher like-for-like valuations across the market, this brings the US share of the index down to 45%. The downside of equal-weighted strategies is that turnover is higher. Until there’s a real-world performance record for this ETF, we can’t see how well the manager manages to optimise the portfolio-management process to reduce the drag of trading costs from this.
I’d like to have the option of a GDP-weighted index fund, which uses capitalisation weighting on a country level but sets each country’s share of the index in line with its share of world GDP. The MSCI World GDP Weighted has 49% in the US, while the MSCI ACWI GDP Weighted (which includes emerging markets) has 30%. Both have beaten the equal-weighted indices over 10 years, but there are still no ETFs that track them. But we can combine regional or country ETFs to get closer to these weights. At its simplest, you could hold a US fund alongside the Xtrackers MSCI World ex US ETF (LSE: EXUS) in a 30%/70% or 50%/50% mix, or whatever ratio you prefer.
This article was first published in MoneyWeek's magazine. Enjoy exclusive early access to news, opinion and analysis from our team of financial experts with a MoneyWeek subscription.
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Cris Sholto Heaton is an investment analyst and writer who has been contributing to MoneyWeek since 2006 and was managing editor of the magazine between 2016 and 2018. He is especially interested in international investing, believing many investors still focus too much on their home markets and that it pays to take advantage of all the opportunities the world offers. He often writes about Asian equities, international income and global asset allocation.
Cris began his career in financial services consultancy at PwC and Lane Clark & Peacock, before an abrupt change of direction into oil, gas and energy at Petroleum Economist and Platts and subsequently into investment research and writing. In addition to his articles for MoneyWeek, he also works with a number of asset managers, consultancies and financial information providers.
He holds the Chartered Financial Analyst designation and the Investment Management Certificate, as well as degrees in finance and mathematics. He has also studied acting, film-making and photography, and strongly suspects that an awareness of what makes a compelling story is just as important for understanding markets as any amount of qualifications.
-
Which investments can I hold in a stocks and shares ISA – and which ones are banned?
HMRC has a list stating which investments are allowed in ISAs, but sometimes investors, and even ISA providers, get confused by the rules. Here’s what you need to know when picking your investments.
By Ruth Emery
-
Review: Andronis Minois and Andronis Arcadia – two Greek island idylls
Travel Andronis Minois on Paros and Andronis Arcadia on Santorini are two beautiful, authentic hotels on two different islands in Greece
By Nicole García Mérida
-
Out of America's shadow: Why Trump's tariff chaos may be good for non-US stocks
Opinion Upending global investment and trade could benefit other countries at the expense of the US market, says Cris Sholto Heaton
By Cris Sholto Heaton
-
LendInvest: a promising fintech firm going cheap
Opinion LendInvest has made some mistakes in the past, but it’s now primed for growth, says Rupert Hargreaves
By Rupert Hargreaves
-
Klarna postpones US IPO as Trump's tariffs rattle markets
Buy-now-pay-later lender Klarna has postponed its US initial public offering owing to the market turbulence. It is not alone, says Matthew Partridge
By Dr Matthew Partridge
-
The star small and mid-cap stocks income investors have overlooked
Opinion Thomas Moore, senior investment director, Aberdeen, highlights three company stocks as he shares where he would put his money
By Thomas Moore
-
Falling revenues and mounting debt spell trouble for Jumia Technologies
Struggling African e-commerce platform Jumia Technologies looks headed for the exit, says Dr Matthew Partridge.
By Dr Matthew Partridge
-
Chemring Group: an explosive investment opportunity in defence
European states are raising their military spending, and Chemring Group looks well placed to profit
By Rupert Hargreaves
-
Best of British bargains: cash in on undervalued companies in the UK stock market
Opinion Michael Field, Chief Equity Market Strategist, EMEA, Morningstar, selects three attractive UK stocks where he'd put his money
By Michael Field
-
PZ Cussons share price down 75% in last decade – why it's one to watch
Opinion Once-strong consumer-goods business PZ Cussons is out of favour with the market. That spells opportunity for investors, says Jamie Ward
By Jamie Ward